Treatment cost effectiveness in acute otitis media: A watch-and-wait approach versus amoxicillin

Paediatrics and Child Health

Volumn 15, Issue 7, 2010, Pages

  Gaboury, Isabelle ^a,b   Coyle, Kathryn ^c   Coyle, Douglas ^c,d   Le Saux, Nicole ^c  

^a CHILDREN S HOSPITAL OF EASTERN ONTARIO   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

^c UNIVERSITY OF OTTAWA   (Canada)

^d OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

Author keywords

Acute otitis media; Cost effectiveness; Economic analysis; Randomized controlled trial

Indexed keywords

EID: 77956893724     PISSN: 12057088     EISSN: None     Source Type: Journal    
DOI: 10.1093/pch/15.7.e14     Document Type: Article

References (27)

1. Paradise JL, Rockette HE, Colborn DK, et al. Otitis media in 2253 Pittsburgh-area infants: Prevalence and risk factors during the first two years of life. Pediatrics 1997;99:318-33.
2. Daly KA, Giebink GS. Clinical epidemiology of otitis media. Pediatr Infect Dis J 2000;19(5 Suppl):S31-6.
3. Schappert SM. Office visits for otitis media: United States, 1975-90. Adv Data 1992:1-19.
4. Gates GA. Cost-effectiveness considerations in otitis media treatment. Otolaryngol Head Neck Surg 1996;114:525-30.
5. Froom J, Culpepper L, Green LA, et al. A cross-national study of acute otitis media: Risk factors, severity, and treatment at initial visit. Report from the International Primary Care Network (IPCN) and the Ambulatory Sentinel Practice Network (ASPN). J Am Board Fam Pract 2001;14:406-17.
6. Froom J, Culpepper L, Jacobs M, et al. Antimicrobials for acute otitis media? A review from the International Primary Care Network. BMJ 1997;315:98-102.
7. van Buchem FL, Peeters MF, van't Hof MA. Acute otitis media: A new treatment strategy. Br Med J (Clin Res Ed) 1985;290:1033-7.
8. Capra AM, Lieu TA, Black SB, Shinefield HR, Martin KE, Klein JO. Costs of otitis media in a managed care population. Pediatr Infect Dis J 2000;19:354-5.
9. Niemela M, Uhari M, Mottonen M, Pokka T. Costs arising from otitis media. Acta Paediatr 1999;88:553-6.
10. Berman S, Byrns PJ, Bondy J, Smith PJ, Lezotte D. Otitis media-related antibiotic prescribing patterns, outcomes, and expenditures in a pediatric medicaid population. Pediatrics 1997;100:585-92.
11. Coyte PC, Asche CV, Elden LM. The economic cost of otitis media in Canada. Int J Pediatr Otorhinolaryngol 1999;49:27-36.
12. Gonzalez-Vallejo C, Sorum PC, Stewart TR, Chessare JB, Mumpower JL. Physicians' diagnostic judgments and treatment decisions for acute otitis media in children. Med Decis Making 1998;18:149-62.
13. Alsarraf R, Gates GA. The real cost of otitis media. Acta Paediatr 1999;88:487-8.
14. Spiro DM, Tay KY, Arnold DH, Dziura JD, Baker MD, Shapiro ED. Wait-and-see prescription for the treatment of acute otitis media: A randomized controlled trial. JAMA 2006;296:1235-41.
15. Chao JH, Kunkov S, Reyes LB, Lichten S, Crain EF. Comparison of two approaches to observation therapy for acute otitis media in the emergency department. Pediatrics 2008;121:e1352-6.
16. Le Saux N, Gaboury I, Baird M, et al. A randomized, double-blind, placebo-controlled noninferiority trial of amoxicillin for clinically diagnosed acute otitis media in children 6 months to 5 years of age. CMAJ 2005;172:335-41.
17. Statistics Canada. Earnings, average hourly for hourly paid employees, by province and territory. 〈www40.statcan.ca/l01/cst01/labr80-eng.htm〉 (Accessed on July 29, 2010).
18. Ministry of Health and Long-term Care. Ontario Drug Benefit Formulary/Comparative Drug Index. 〈www.health.gov.on.ca/english/providers/ program/drugs/odbf-mn.html〉 (Accessed on July 29, 2010).
19. Claxton K. The irrelevance of inference: A decision-making approach to the stochastic evaluation of health care technologies. J Health Econ 1999;18:341-64.
20. Campbell MK, Torgerson DJ. Bootstrapping: Estimating confidence intervals for cost-effectiveness ratios. QJM 1999;92:177-82.
21. Forgie S, Zhanel G, Robinson J. Management of acute otitis media. Paediatr Child Health 2009;14:457-64.
22. Samore MH, Magill MK, Alder SC, et al. High rates of multiple antibiotic resistance in Streptococcus pneumoniae from healthy children living in isolated rural communities: Association with cephalosporin use and intrafamilial transmission. Pediatrics 2001;108:856-65.
23. Finkelstein JA, Huang SS, Daniel J, et al. Antibiotic-resistant Streptococcus pneumoniae in the heptavalent pneumococcal conjugate vaccine era: Predictors of carriage in a multicommunity sample. Pediatrics 2003;112:862-9.
24. Barkai G, Greenberg D, Givon-Lavi N, Dreifuss E, Vardy D, Dagan R. Community prescribing and resistant Streptococcus pneumoniae. Emerg Infect Dis 2005;11:829-37.
25. Low DE, Pichichero ME, Schaad UB. Optimizing antibacterial therapy for community-acquired respiratory tract infections in children in an era of bacterial resistance. Clin Pediatr (Phila) 2004;43:135-51.
26. Benito MB, Gorricho BP. Acute mastoiditis: Increase in the incidence and complications. Int J Pediatr Otorhinolaryngol 2007;71:1007-11.
27. Coyle D, Lee KM. The problem of protocol driven costs in pharmacoeconomic analysis. Pharmacoeconomics 1998;14:357-63.